Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
abbreviation
|
| gptkbp:administeredBy |
oral route
intramuscular injection |
| gptkbp:affiliatedWith |
hydrazide chemical class
|
| gptkbp:ATCCode |
J04AC01
|
| gptkbp:combines |
gptkb:rifampicin
gptkb:ethambutol gptkb:pyrazinamide |
| gptkbp:contraindication |
severe liver disease
|
| gptkbp:discoveredIn |
1952
|
| https://www.w3.org/2000/01/rdf-schema#label |
INH
|
| gptkbp:includedIn |
gptkb:World_Health_Organization's_List_of_Essential_Medicines
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
inhibits synthesis of mycolic acids in mycobacteria
|
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:sideEffect |
peripheral neuropathy
hepatotoxicity |
| gptkbp:standsFor |
gptkb:isoniazid
|
| gptkbp:usedFor |
treatment of tuberculosis
|
| gptkbp:bfsParent |
gptkb:Inhambane_Airport
gptkb:Ingham_railway_station |
| gptkbp:bfsLayer |
7
|